Study ID: C38072-AS-30027 | 2015-001580-39
Study Title
- An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
Teva Identifier
- C38072-AS-30027 | 2015-001580-39
ClinicalTrials.gov Identifier
- NCT02501629
Study Status
- Completed
Trial Condition(s)
- Asthma | Elevated Blood Eosinophils | Oral Corticosteroid Dependence
Interventions
- Drug: Reslizumab | Drug: Placebo | Drug: Non-Oral Corticosteroid (non-OCS) Asthma Medication | Drug: Oral Corticosteroid (OCS)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- September 29, 2015 - December 4, 2017
Phase
- Phase 3
Study Type
Interventional
